Ian Michael Estepan, Chief Financial Officer at Sarepta Therapeutics, Inc. (SRPT), sold 1,565 shares at $128.30 ($200K) on 2024-03-01, disclosed to the SEC on 2024-03-05.
Seasonal sale ($200k) by Chief Financial Officer — this insider has traded SRPT in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $126.19 | 365 | $46K | 23.0% |
| 2 | $128.30 | 1,200 | $154K | 77.0% |
| Total | $127.81 avg | 1,565 | $200K | 100% |
| Filing → |